Merck changes French set-up:
This article was originally published in Clinica
Executive Summary
Merck KGaA has reorganised its activities in France into one company to be known as Merck Lipha. The reorganisation involves the merging of Merck Clevenot, which manufactures diagnostic reagents and lab equipment, with pharmaceutical manufacturer, Lipha. Jean-Noel Treilles, currently president of Lipha, will head the new company and Karl Heinz Peter, president of Merck Clevenot, will become vice-president.